AllianceBernstein L P Rotates Inside AI, Hedges With Value in 2026-Q1

The biggest dollar add wasn’t a stock; it was their own AB Active ETF EMOP, boosted by +2212.1% to $1.24B. That position, alongside bigger stakes in IVV, IXUS, and ITOT, tells you they want more levers to dial beta and liquidity without stock-picking every turn. Under the ETF umbrella, the real stock story is a shift from headline AI to infrastructure, tools, and durable compounders.

• EMOP: A +$1.18B add turns the in-house active ETF into a core risk-budget tool.
• GE Aerospace: A +333.3% surge to $1.46B is a bold bet on aero-cycle and defense cash flows.
• Apple: A +4.9% increase to $11.6B bucks the trend of trimming megacap tech, backing its ecosystem stickiness.
• Berkshire Hathaway: A +25.7% lift to $2.20B inserts a diversified, cash-rich value anchor into a growth-heavy book.
• Verisk Analytics: A +30.9% add to $1.62B, despite sitting -28.8% vs cost, signals high conviction in its data-moat economics.
• Shopify and Cadence: +34.6% and +26.4% increases, respectively, show preference for mission-critical software and commerce tooling over pure ad-driven platforms.
• Exxon and Merck: +37.9% and +30.9% increases build out energy and pharma as defensive and inflation-hedging legs.

Sprinkled around these are smaller but telling adds to Tesla, TJX, Monster Beverage, Veeva, and AppLovin. Together they read as a bet that the next leg of performance comes from enablers, rails, and cash-generative cyclicals, not just the top four AI champions.

The funding leg for this rotation is crystal clear: monetize outsized winners and de-emphasize parts of the stack where upside-to-risk now looks less compelling. The biggest check came from Microsoft, where they cut shares -11.9%, pulling about $2.07B of capital out of a position still up 291.5% vs cost.

• Nvidia and Alphabet (GOOG): Modest -2.6% and -2.5% trims, but on huge bases ($18.4B and $12.1B), quietly recycle almost $800M.
• Amazon: A -2.4% reduction into strength, still a $12.2B pillar, suggests position-sizing discipline rather than a thesis change.
• Taiwan Semi and Applied Materials: -17.0% and -14.9% cuts show less appetite for more cyclical, capex-driven corners of the semiconductor chain.
• AbbVie and Vertex: Double-digit reductions (-19.3% and -13.0%) indicate profit-taking in high-performing biopharma where valuation risk is rising.
• CBOE, ADP, Thermo Fisher, McKesson: Trims in high-quality, fairly fully-valued compounders free up capital for names where the team sees better entry points.

They also dialed back Walmart (-16.4%), Wells Fargo (-11.2%), and Johnson & Johnson (-9.7%). Those moves look less like macro calls and more like housecleaning: recycle mature gains into higher-conviction ideas and into the new ETF risk sleeves.

On the surface, sector weights barely moved: tech slipped just 0.35 percentage points and consumer, healthcare, and financials are all down marginally. The real tell is the rise of their “Unclassified” bucket — ETFs and Berkshire — from 5.18% to 6.32%, giving AllianceBernstein a more flexible chassis around the same growth core.

Within technology, they nudged away from pure semis and megacap platforms toward design tools (Cadence), analytics (Verisk), and commerce/cloud infrastructure (Shopify, Veeva). That’s an internal rotation from direct AI winners to the software and data rails that monetize AI over longer cycles.

Healthcare slipped from 11.49% to 10.96%, as they trimmed several big pharma and medtech names while adding Merck and Intuitive Surgical. Finance eased to 5.33% from 5.62%, with banks and brokers a mild source of funds despite a larger Bank of America stake.

Consumer exposure is being re-angled: they cut Costco, Home Depot, Disney, and Walmart, and leaned into Netflix, TJX, and Monster. Energy grew from 0.51% to 0.71% on the back of Exxon, and Industrials ticked up via GE and Verisk, pointing to a quiet re-risking into quality cyclicals tied to real-economy demand and defense spending.

Taken together, this is not a manager backing away from AI or U.S. growth; it’s a manager rebuilding the scaffolding around those bets so they can stay long through more volatility. They are willing sellers of oversized, highly appreciated positions and selective buyers of underappreciated rails, cyclicals, and their own multi-asset wrappers.

Expect them to keep a structurally high tech weight, but with more of the incremental dollar going into tools (Cadence, Verisk, Shopify, Veeva) and into flexible wrappers (EMOP, IVV, IXUS, ITOT) rather than merely topping up the “Magnificent Seven.”

The enhanced stakes in Berkshire, Exxon, Merck, GE Aerospace, and Monster suggest they want durable free cash flow that can carry the book if AI sentiment sours. At the margin, the consumer tilt toward off-price and streaming over big-box retail speaks to a view that the next phase of the cycle will reward value-conscious and subscription-based demand.

Investors reading this 13F should see a manager who used a tough -10.03% quarter to upgrade quality, broaden their toolset, and lean further into secular data and software rails — all without abandoning the growth engines that drove their strong 3- and 5-year records.